BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10649724)

  • 21. Recent advances in diabetic nephropathy.
    Marshall SM
    Postgrad Med J; 2004 Nov; 80(949):624-33. PubMed ID: 15537844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
    Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorenal protection in diabetes.
    Pickering TG
    Heart Dis; 2000; 2(2):S18-22. PubMed ID: 11728259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic diseases management in the Jamaican setting: HOPE worldwide Jamaica's experience.
    Swaby P; Wilson E; Swaby S; Sue-Ho R; Pierre R
    P N G Med J; 2001; 44(3-4):171-5. PubMed ID: 12422988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
    Ruilope LM; Segura J
    J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C; Oberbauer R
    Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic nephropathy in its early stages.
    Deferrari G; Ravera M; Berruti V
    Diabetes Metab Res Rev; 2003; 19(2):101-14. PubMed ID: 12673778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
    Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes and clinical laboratory tests: team medicine].
    Matsui K
    Rinsho Byori; 2011 Nov; 59(11):1050-4. PubMed ID: 22352019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A collaborative approach to diabetes nephropathy prevention.
    Jindal K; MacNair L; Senior P
    Alta RN; 2005 Oct; 61(9):10-1. PubMed ID: 16270812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of uremic diabetics: standards for good clinical practice. ALFEDIAM and Society of Nephrology expert meeting].
    Diabetes Metab; 1999 Dec; 25 Suppl 5():1-72. PubMed ID: 10619121
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance.
    Ikeda A; Fujii M; Ohno Y; Godai K; Li Y; Nakamura Y; Yabe D; Tsushita K; Kashihara N; Kamide K; Kabayama M
    J Diabetes Investig; 2023 Jun; 14(6):782-791. PubMed ID: 36960735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrition interventions in early diabetic renal disease.
    Rais-Keeley P
    Diabetes Educ; 2002; 28(1):62-6, 69-70. PubMed ID: 11852745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional intervention for a patient with diabetic nephropathy.
    Kim HY
    Clin Nutr Res; 2014 Jan; 3(1):64-8. PubMed ID: 24527422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the ambulatory diabetic patient.
    RUNYAN JW; HURWITZ D
    N Engl J Med; 1954 Mar; 250(9):361-5. PubMed ID: 13133081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.